DRUG
Bright Minds Biosciences Inc
51.80$
-3.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | – | – | – | +1,100.1% | – | – | |
| – | – | – | – | – | – | – | |
| – | +181.6% | +1,679.3% | +92.9% | -59.0% | -76.4% | +839.4% | |
| – | -4.8% | +1,271.3% | +39.0% | +4.1% | -32.5% | +52.1% | |
| – | +98.8% | +1,733.2% | +74.0% | -50.7% | -61.8% | +393.8% | |
| – | – | – | – | – | – | – | |
| – | – | – | – | -91.1% | – | – | |
| – | – | – | – | – | – | – | |
| – | – | -2,532.4% | – | -106.4% | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.